Gene · 10645
Papers2,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BAY-3827 and SBI-0206965: Potent AMPK Inhibitors That Paradoxically Increase Thr172 Phosphorylation. | Int J Mol Sci | 2023 | 38203624 | PubTator, text mining | PubMed |
| Green Synthesis and Characterization of Silver Nanoparticles Using Azadirachta indica Seeds Extract: In Vitro and In Vivo Evaluation of Anti-Diabetic Activity. | Pharmaceuticals (Basel) | 2023 | 38139804 | PubTator, text mining | PubMed |
| Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue. | Life (Basel) | 2023 | 38137946 | PubTator, text mining | PubMed |
| Domestic Animal Models of Central Nervous System Tumors: Focus on Meningiomas. | Life (Basel) | 2023 | 38137885 | PubTator, text mining | PubMed |
| Extracellular Superoxide Dismutase Attenuates Hepatic Oxidative Stress in Nonalcoholic Fatty Liver Disease through the Adenosine Monophosphate-Activated Protein Kinase Activation. | Antioxidants (Basel) | 2023 | 38136160 | PubTator, text mining | PubMed |
| Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. | J Xenobiot | 2023 | 38132710 | PubTator, text mining | PubMed |
| Novel insights into the regulatory role of N6-methyladenosine methylation modified autophagy in sepsis. | Aging (Albany NY) | 2023 | 38112620 | PubTator, text mining | PubMed |
| Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice. | Nat Commun | 2023 | 38110408 | PubTator, text mining | PubMed |
| The expanding Pandora's toolbox of CD8+T cell: from transcriptional control to metabolic firing. | J Transl Med | 2023 | 38082437 | PubTator, text mining | PubMed |
| Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway. | J Transl Med | 2023 | 38082327 | PubTator, text mining | PubMed |
| Advances in the study of miRNAs in chronic kidney disease with cardiovascular complications. | Front Physiol | 2023 | 38074330 | PubTator, text mining | PubMed |
| The Role of Cdc42 in the Insulin and Leptin Pathways Contributing to the Development of Age-Related Obesity. | Nutrients | 2023 | 38068822 | PubTator, text mining | PubMed |
| Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies. | Molecules | 2023 | 38067472 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| The role of AMPK in macrophage metabolism, function and polarisation. | J Transl Med | 2023 | 38066566 | PubTator, text mining | PubMed |
| Establishment and Analysis of an Artificial Neural Network Model for Early Detection of Polycystic Ovary Syndrome Using Machine Learning Techniques. | J Inflamm Res | 2023 | 38050562 | PubTator, text mining | PubMed |
| CaMKK2 and CHK1 phosphorylate human STN1 in response to replication stress to protect stalled forks from aberrant resection. | Nat Commun | 2023 | 38036565 | PubTator, text mining | PubMed |
| Goldfish adiponectin: (I) molecular cloning, tissue distribution, recombinant protein expression, and novel function as a satiety factor in fish model. | Front Endocrinol (Lausanne) | 2023 | 38027109 | PubTator, text mining | PubMed |
| Editorial: Calcium signaling in cancer immunity. | Front Immunol | 2023 | 38022525 | PubTator, text mining | PubMed |
| Dihydroartemisinin inhibits liver cancer cell migration and invasion by reducing ATP synthase production through CaMKK2/NCLX. | Oncol Lett | 2023 | 38020296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10645/papers?page=11